Search

everythinglearnresearchcommunity

for

Search:↓

Increased pigmentation may protect skin from UVB, new targets for skin disease treatments were identified, sunscreen ingredients don't affect hormones, TNF-α inhibitors may help diabetic wounds, and certain treatments could prevent chemotherapy-induced hair loss.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

miR-181a-5p helps hair growth by activating a specific signaling pathway.

Tofacitinib may effectively treat folliculitis decalvans.

CRF can cause hair loss, but blocking its receptors might prevent this.

Ruxolitinib reduced inflammation and improved symptoms in APECED patients but may cause anemia and weight gain.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Ritlecitinib is a new treatment for severe hair loss in people 12 and older.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Arg1+ macrophages may play a role in Alopecia Areata, offering new treatment targets.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Blocking the Wnt pathway could lead to new treatments for cancer and tissue repair but requires careful development to avoid side effects.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

The document concludes that there are no effective clinical treatments for hearing loss due to hair cell damage, but research is ongoing.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Targeting Hedgehog signaling may help treat ligamentum flavum fibrosis.

AKR1B10 enzyme may cause keloid scars and could be a treatment target.

A natural steroid in the body may protect against eye damage in glaucoma.

Immune cells affect hair growth and could lead to new hair loss treatments.

New treatments for PCOS are improving fertility and managing symptoms better.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Ritlecitinib shows promise as a versatile treatment for various autoimmune and inflammatory diseases.

Overactive Wnt signaling in mouse skin stem cells causes acne-like cysts and shrinking oil glands, which some treatments can partially fix.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.